A second Princeton resident has died from COVID-19, the Princeton Health Department announced on April 8.
The man was more than 80 years old and had pre-existing health conditions, officials said. He was under care at the Princeton Care Center nursing home on Bunn Drive. He was moved to an isolated wing of the nursing home immediately when he tested positive for COVID-19, according to officials.
The Princeton Health Department is investigating potential exposure to other residents and staff at the nursing home. Non-essential visitation to the Princeton Care Center was suspended in mid-March, and universal masking procedures are in place, according to the statement.
The man’s death follows the death of a 92-year-old woman who died of COVID-19 earlier this month. She may have acquired COVID-19 through contact with a home health aide, officials said.
The Princeton man is among the 28 Mercer County residents who have died of COVID-19 as of April 8, the New Jersey Department of Health said. To date, 992 Mercer County residents have been infected with the disease.
Princeton Health Department officials said that as of April 8, there were 45 Princeton residents who had tested positive for COVID-19. Officials said 25 residents were men and 20 were women.
Two of the Princeton residents were under 18 years old, and 33 were between 18 years old and 65 years old. Ten were older than 66 years old, the Princeton Health Department said.
Mercer County has opened an appointment-only, drive-through testing center for COVID-19 on in a parking lot at the Quaker Bridge Mall in Lawrence Township. The testing site is a collaborative effort between Mercer County and several Mercer County hospitals.
Mercer County residents who have contracted COVID-19 may obtain the prescription drug combination of hydroxychloroquine sulfate and the antibiotic Zithromax to treat their symptoms through the Greenhill Pharmacy in East Windsor.
The drug combination is available to all Mercer County residents whose physician has prescribed it for them. The Federal Drug Administration has issued an emergency-use authorization for the drug combination to treat and mitigate the effects of COVID-19.
